• COO Maneesh Goyal argues de-identified data still risks re-identification with advanced compute. • Mayo Clinic Platform’s Orchestrate platform offers pharma/medtech access to rich, high‑quality data. • Privacy strategy replaces identifiers with fictitious personas, preserving clinical notes for research. • Orchestrate now delivers standardized real‑world cancer data to researchers and partners. • The approach balances patient privacy with the need for actionable data in drug discovery. • Mayo emphasizes that true protection requires more than HIPAA Safe Harbor de‑identification.
Article Summaries:
- Maneesh Goyal, chief operating officer of Mayo Clinic Platform, is a big believer in patient privacy, but not the way it has commonly come to be represented in the healthcare world: de-identified data, according to the HIPAA Safe Harbor method. “A lot of organizations will take patient data and de-identify it, and once it is de-identified, it is no longer considered HIPAA data,” Goyal said in a recent interview. “We think that is interesting, but not sufficient to protect the patient data because, especially as you have more and more compute, you can actually figure it out.” In a recent interv
Sources: